NCT04513808View on ClinicalTrials.gov

Total Intravenous Anesthesia and Recurrence Free Survival

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,614

Participants

Timeline

Start Date

August 15, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Esophageal Cancer
Interventions
DRUG

Propofol-based total intravenous anesthesia

Propofol-based total intravenous anesthesia, titrated to clinical need.

DRUG

Sevoflurane intravenous anesthesia

Sevoflurane intravenous anesthesia, titrated to clinical need.

Trial Locations (1)

Unknown

RECRUITING

Shanhai Chest Hospital, Shanghai

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT04513808 - Total Intravenous Anesthesia and Recurrence Free Survival | Biotech Hunter | Biotech Hunter